United States Anti-Doping Agency Reauthorization Act

Bill: 113-s-2338
Sponsor: full_name: Sen. Rockefeller, John D., IV [D-WV]
Introduced: 2014-05-14
Policy area: Sports and Recreation
Subjects: Athletes

Drug, alcohol, tobacco use

Olympic games
Latest action: action_date: 2014-12-18
text: Became Public Law No: 113-280.

Summaries:
action_date: 2014-05-14
action_desc: Introduced in Senate
text: <p>United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.</p>

action_date: 2014-12-01
action_desc: Reported to Senate without amendment
text: <p><b>(This measure has not been amended since it was introduced. The summary of that version is repeated here.)</b></p> <p>United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.</p>

action_date: 2014-12-11
action_desc: Passed Senate without amendment
text: <p><b>(This measure has not been amended since it was introduced. The summary of that version is repeated here.)</b></p> <p>United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.</p>

action_date: 2014-12-12
action_desc: Passed House without amendment
text: <p><b>(This measure has not been amended since it was introduced. The summary of that version is repeated here.)</b></p> <p>United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.</p>

action_date: 2014-12-18
action_desc: Public Law
text: <p><b>(This measure has not been amended since it was introduced. The summary of that version is repeated here.)</b></p> <p>United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.</p>

tv_txt: II 113th CONGRESS 2d Session S. 2338 IN THE SENATE OF THE UNITED STATES May 14, 2014 Mr. Rockefeller (for himself and Mr. Thune ) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation A BILL To reauthorize the United States Anti-Doping Agency, and for other purposes.

1. Short title This Act may be cited as the United States Anti-Doping Agency Reauthorization Act . 2. Prohibit performance-enhancing methods Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2001 ) is amended— (1) in subsection (a), by striking paragraph (4); and (2) in subsection (b)— (A) in paragraph (1), by inserting and be recognized worldwide as the independent national anti-doping organization for the United States after Committee ; (B) in paragraph (2), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (C) in paragraph (3), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (D) in paragraph (4), by striking and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and and inserting , and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency. ; and (E) by striking paragraph (5). 3. Authorization of appropriations Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2003 ) is amended to read as follows: 703. Authorization of appropriations There are authorized to be appropriated to the United States Anti-Doping Agency— (1) for fiscal year 2014, $11,300,000; (2) for fiscal year 2015, $11,700,000; (3) for fiscal year 2016, $12,300,000; (4) for fiscal year 2017, $12,900,000; (5) for fiscal year 2018, $13,500,000; (6) for fiscal year 2019, $14,100,000; and (7) for fiscal year 2020, $14,800,000. .

tv_txt: One Hundred Thirteenth Congress of the United States of America 2d Session Begun and held at the City of Washington on Friday, the third day of January, two thousand and fourteen S. 2338 IN THE SENATE OF THE UNITED STATES AN ACT To reauthorize the United States Anti-Doping Agency, and for other purposes.

1. Short title This Act may be cited as the United States Anti-Doping Agency Reauthorization Act . 2. Prohibit performance-enhancing methods Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2001 ) is amended— (1) in subsection (a), by striking paragraph (4); and (2) in subsection (b)— (A) in paragraph (1), by inserting and be recognized worldwide as the independent national anti-doping organization for the United States after Committee ; (B) in paragraph (2), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (C) in paragraph (3), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (D) in paragraph (4), by striking and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and and inserting , and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency. ; and (E) by striking paragraph (5). 3. Authorization of appropriations Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2003 ) is amended to read as follows: 703. Authorization of appropriations There are authorized to be appropriated to the United States Anti-Doping Agency— (1) for fiscal year 2014, $11,300,000; (2) for fiscal year 2015, $11,700,000; (3) for fiscal year 2016, $12,300,000; (4) for fiscal year 2017, $12,900,000; (5) for fiscal year 2018, $13,500,000; (6) for fiscal year 2019, $14,100,000; and (7) for fiscal year 2020, $14,800,000. .

Speaker of the House of Representatives Vice President of the United States and President of the Senate

tv_txt: 113th CONGRESS 2d Session S. 2338 IN THE SENATE OF THE UNITED STATES AN ACT To reauthorize the United States Anti-Doping Agency, and for other purposes.

1. Short title This Act may be cited as the United States Anti-Doping Agency Reauthorization Act . 2. Prohibit performance-enhancing methods Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2001 ) is amended— (1) in subsection (a), by striking paragraph (4); and (2) in subsection (b)— (A) in paragraph (1), by inserting and be recognized worldwide as the independent national anti-doping organization for the United States after Committee ; (B) in paragraph (2), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (C) in paragraph (3), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (D) in paragraph (4), by striking and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and and inserting , and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency. ; and (E) by striking paragraph (5). 3. Authorization of appropriations Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2003 ) is amended to read as follows: 703. Authorization of appropriations There are authorized to be appropriated to the United States Anti-Doping Agency— (1) for fiscal year 2014, $11,300,000; (2) for fiscal year 2015, $11,700,000; (3) for fiscal year 2016, $12,300,000; (4) for fiscal year 2017, $12,900,000; (5) for fiscal year 2018, $13,500,000; (6) for fiscal year 2019, $14,100,000; and (7) for fiscal year 2020, $14,800,000. .

Passed the Senate December 11, 2014. Secretary

tv_txt: II Calendar No. 608 113th CONGRESS 2d Session S. 2338 [Report No. 113–281] IN THE SENATE OF THE UNITED STATES May 14, 2014 Mr. Rockefeller (for himself, Mr. Thune , and Mr. Blunt ) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation December 1, 2014 Reported by Mr. Rockefeller , without amendment A BILL To reauthorize the United States Anti-Doping Agency, and for other purposes.

1. Short title This Act may be cited as the United States Anti-Doping Agency Reauthorization Act . 2. Prohibit performance-enhancing methods Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2001 ) is amended— (1) in subsection (a), by striking paragraph (4); and (2) in subsection (b)— (A) in paragraph (1), by inserting and be recognized worldwide as the independent national anti-doping organization for the United States after Committee ; (B) in paragraph (2), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (C) in paragraph (3), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (D) in paragraph (4), by striking and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and and inserting , and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency. ; and (E) by striking paragraph (5). 3. Authorization of appropriations Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2003 ) is amended to read as follows: 703. Authorization of appropriations There are authorized to be appropriated to the United States Anti-Doping Agency— (1) for fiscal year 2014, $11,300,000; (2) for fiscal year 2015, $11,700,000; (3) for fiscal year 2016, $12,300,000; (4) for fiscal year 2017, $12,900,000; (5) for fiscal year 2018, $13,500,000; (6) for fiscal year 2019, $14,100,000; and (7) for fiscal year 2020, $14,800,000. .

December 1, 2014 Reported without amendment